Expression of elongation factor (EF)-Tu is correlated with prognosis of gastric adenocarcinomas

International Journal of Molecular Sciences

Volumn 12, Issue 10, 2011, Pages 6645-6655

  Xu, Chaoyang ^a,b   Wang, Jianjun ^c   Li, Jiajia ^a   Fang, Rengui ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Department of Surgical Oncology   (China)

Author keywords

Elongation factor Tu; Gastric cancer; Survival

Indexed keywords

ELONGATION FACTOR TU;

ADULT; ADVANCED CANCER; ARTICLE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; GASTRECTOMY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC CORRELATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; STOMACH ADENOCARCINOMA; STOMACH MUCOSA; ADENOCARCINOMA; AGED; DOWN REGULATION; FOLLOW UP; METABOLISM; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; STOMACH NEOPLASMS; SURVIVAL RATE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DOWN-REGULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PEPTIDE ELONGATION FACTOR TU; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 80055042581     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12106645     Document Type: Article

References (33)

1. Hohenberger, P.; Gretschel, S. Gastric cancer. Lancet 2003, 362, 305-315.
2. Dicken, B.J.; Bigam, D.L.; Cass, C.; Mackey, J.R.; Joy, A.A.; Hamilton, S.M. Gastric adenocarcinoma: Review and considerations for future directions. Ann. Surg. 2005, 241, 27-39.
3. Zhang, B.; Cao, W.; Zhang, F.; Zhang, L.; Niu, R.; Niu, Y.; Fu, L.; Hao, X.; Cao, X. Protein interacting with C alpha kinase 1 (PICK1) is involved in promoting tumor growth and correlates with poor prognosis of human breast cancer. Cancer Sci. 2010, 101, 1536-1542.
4. Parmeggiani, A.; Nissen, P. Elongation factor Tu-targeted antibiotics: Four different structures, two mechanisms of action. FEBS Lett. 2006, 580, 4576-4581.
5. Suzuki, H.; Ueda, T.; Taguchi, H.; Takeuchi, N. Chaperone properties of mammalian mitochondrial translation elongation factor Tu. J. Biol. Chem. 2007, 282, 4076-4084.
6. Caldas, T.D.; El Yaagoubi, A.; Richarme, G. Chaperone properties of bacterial elongation factor EF-Tu. J. Biol. Chem. 1998, 273, 11478-11482.
7. Archambaud, C.; Gouin, E.; Pizarro-Cerda, J.; Cossart, P.; Dussurget, O. Translation elongation factor EF-Tu is a target for Stp, a serine-threonine phosphatase involved in virulence of Listeria monocytogenes. Mol. Microbiol. 2005, 56, 383-396.
8. Sakai, J.; Ishikawa, H.; Kojima, S.; Satoh, H.; Yamamoto, S.; Kanaoka, M. Proteomic analysis of rat heart in ischemia and ischemia-reperfusion using fluorescence two-dimensional difference gel electrophoresis. Proteomics 2003, 3, 1318-1324.
9. Shin, J.H.; London, J.; Le Pecheur, M.; Höger, H.; Pollak, D.; Lubec, G. Aberrant neuronal and mitochondrial proteins in hippocampus of transgenic mice overexpressing human Cu/Zn superoxide dismutase 1. Free Radic. Biol. Med. 2004, 37, 643-653.
10. Wells, J.; Henkler, F.; Leversha, M.; Koshy, R. A mitochondrial elongation factor-like protein is over-expressed in tumours and differentially expressed in normal tissues. FEBS Lett. 1995, 358, 119-125.
11. Grant, A.G.; Flomen, R.M.; Tizard, M.L.; Grant, D.A. Differential screening of a human pancreatic adenocarcinoma lambda gt11 expression library has identified increased transcription of elongation factor EF-1 alpha in tumour cells. Int. J. Cancer 1992, 50, 740-745.
12. Srisomsap, C.; Sawangareetrakul, P.; Subhasitanont, P.; Panichakul, T.; Keeratichamroen, S.; Lirdprapamongkol, K.; Chokchaichamnankit, D.; Sirisinha, S.; Svasti, J. Proteomic analysis of cholangiocarcinoma cell line. Proteomics 2004, 4, 1135-1144.
13. Koch, I.; Hofschneider, P.H.; Lottspeich, F.; Eckerskorn, C.; Koshy, R. Tumour-related expression of a translation-elongation factor-like protein. Oncogene 1990, 5, 839-843.
14. Kim, H.K.; Park, W.S.; Kang, S.H.; Warda, M.; Kim, N.; Ko, J.H.; Prince, Ael-B.; Han, J. Mitochondrial alterations in human gastric carcinoma cell line. Am. J. Physiol. Cell Physiol. 2007, 293, C761-C771.
15. Parmeggiani, A.; Nissen, P. Elongation factor Tu-targeted antibiotics: Four different structures, two mechanisms of action. FEBS Lett. 2006, 580, 4576-4581.
16. Zuurmond, A.M.; Martien de Graaf, J.; Olsthoorn-Tieleman, L.N.; van Duyl, B.Y.; Mörhle, V.G.; Jurnak, F.; Mesters, J.R.; Hilgenfeld, R.; Kraal, B. GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes. J. Mol. Biol. 2000, 304, 995-1005.
17. Zipfel, C.; Kunze, G.; Chinchilla, D.; Caniard, A.; Jones, J.D.; Boller, T.; Felix, G. Perception of the bacterial PAMP EF-Tu by the receptor EFR restricts Agrobacterium-mediated transformation. Cell 2006, 125, 749-760.
18. Wells, J.; Henkler, F.; Leversha, M.; Koshy, R. A mitochondrial elongation factor-like protein is over-expressed in tumours and differentially expressed in normal tissues. FEBS Lett. 1995, 358, 119-125.
19. Gross, S.R.; Kinzy, T.G. Translation elongation factor 1A is essential for regulation of the actin cytoskeleton and cell morphology. Nat. Struct. Mol. Biol. 2005, 12, 772-778.
20. Kuramitsu, Y.; Baron, B.; Yoshino, S.; Zhang, X.; Tanaka, T.; Yashiro, M.; Hirakawa, K.; Oka, M.; Nakamura, K. Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells. Anticancer Res. 2010, 30, 4459-4465.
21. Rao, T.R.; Slobin, L.I. The stability of mRNA for eucaryotic elongation factor Tu in Friend erythroleukemia cells varies with growth rate. Mol. Cell. Biol. 1988, 8, 1085-1092.
22. Omori, S.; Sato, Y.; Hirakawa, S.; Isobe, T.; Yukawa, M.; Murata, K. Two extra chromosomal genomes of Leucocytozoon caulleryi; complete nucleotide sequences of the mitochondrial genome and existence of the apicoplast genome. Parasitol. Res. 2008, 103, 953-957.
23. Krab, I.M.; Te Biesebeke, R.; Bernardi, A.; Parmeggiani, A. Elongation factor Ts can act as a steric chaperone by increasing the solubility of nucleotide binding-impaired elongation factor-Tu. Biochemistry 2001, 40, 8531-8535.
24. Krab, I.M.; Te Biesebeke, R.; Bernardi, A.; Parmeggiani, A. Chloroplast protein synthesis elongation factor, EF-Tu, reduces thermal aggregation of rubisco activase. J. Plant Physiol. 2007, 164, 1564-1571.
25. Modica-Napolitano, J.S.; Kulawiec, M.; Singh, K.K. Mitochondria and human cancer. Curr. Mol. Med. 2007, 7, 121-131.
26. Modica-Napolitano, J.S.; Singh, K.K. Mitochondrial dysfunction in cancer. Mitochondrion 2004, 4, 755-762.
27. Gogvadze, V.; Orrenius, S.; Zhivotovsky, B. Mitochondria in cancer cells: What is so special about them? Trends Cell Biol. 2008, 18, 165-173.
28. Calabrese, C.; Pisi, A.; Di Febo, G.; Liguori, G.; Filippini, G.; Cervellera, M.; Righi, V.; Lucchi, P.; Mucci, A.; Schenetti, L. et al. Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy. Cancer Epidemiol. Biomarkers Prev. 2008, 17, 1386-1395.
29. Zhang, L.; Li, L.; Liu, H.; Prabhakaran, K.; Zhang, X.; Borowitz, J.L.; Isom, G.E. HIF-1alpha activation by a redox-sensitive pathway mediates cyanide-induced BNIP3 upregulation and mitochondrial-dependent cell death. Free Radic. Biol. Med. 2007, 43, 117-127.
30. Gillies, R.J.; Robey, I.; Gatenby, R.A. Causes and consequences of increased glucose metabolism of cancers. J. Nucl. Med. 2008, 49, 24S-42S.
31. Kondoh, H. Cellular life span and the Warburg effect. Exp. Cell Res. 2008, 314, 1923-1928.
32. Kim, J.W.; Tchernyshyov, I.; Semenza, G.L.; Dang, C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006, 3, 177-185.
33. Papandreou, I.; Cairns, R.A.; Fontana, L.; Lim, A.L.; Denko, N.C. HIF-1 mediates adaptation to hypoxia by actively down regulating mitochondrial oxygen consumption. Cell Metab. 2006, 3, 187-197.